A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

iObserver Version 1.9 Is Released by Caregility: A Continous Virtual Observation & Communications Systems for Monitoring Patients Remotely

November 19, 2020

Caregility, a clinical collaboration and communications company moving the access point of care closer to the patient, announces the release of version 1.9 of its iObserver application, a continuous virtual observation and communications system for remotely monitoring at-risk patients.

iObserver allows clinical teams to remotely observe up to 12 patient rooms on a single screen with two-way audio and video support through the Caregility Platform, a purpose-built, HIPAA-compliant telehealth ecosystem for the entire healthcare continuum.

Caregility leveraged thousands of hours of customer input to build new features and capability into the iObserver v1.9 release. The new version will enhance patient and provider experience and application flexibility with the goals of minimizing adverse events, easing provider burden, and reducing healthcare costs by enabling care teams to do more with less.

Costs associated with the patient sitting are rarely reimbursed and often unbudgeted. With expenses for in-room patient sitters running into the millions, this can have a significant impact on a hospital’s bottom-line and direct care resources.  One Caregility healthcare customer, after deploying iObserver, reported that in eight months of use their unbudgeted sitter hours dropped by 75% with no falls or adverse events.

iObserver enables cost-effective virtual observation across a broad spectrum of use cases, including but not limited to:

  • Clinical deterioration/rapid response events
  • Fall prevention/elopement
  • COVID isolation room – bedside support and room visualization
  • Overflow capacity management
  • Risk to self, from others, or to others

“Caregility is committed to investing in accelerated development that takes into account the experience from both the clinical perspective and the patient perspective,” said Sudhir Ahuja, SVP of Product Development at Caregility. “The iObserver v1.9 release is a great example of taking that input and turning it into a reality for our customers.”

To see a demonstration of how iObserver can help your health system protect patients and drive down costs, as well as unique options we have to help you deal with rising COVID cases with our bedside application that turns any iPad in to a secure communications device in patient rooms, contact Caregility at (732) 440-8040.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.
“We are excited to present the first look at the safety and clinical activity of ELVN-001, which we believe supports the potential for ELVN-001 to address the limitations of the available active-site TKIs,” said Helen Collins, M.D., Chief Medical Officer of Enliven. “Across a wide dose range, ELVN-001 demonstrated activity in a heavily pre-treated patient population that includes post-asciminib patients, with a preliminary safety profile consistent with its highly selective design. Not only did all evaluable patients have improved or stable BCR::ABL1 transcript levels, but, importantly, 89% of all patients enrolled remain on study. We believe the initial data demonstrate the potential clinical utility of ELVN-001 for all types of patients, including those that are earlier in the treatment paradigm.”
The partnership is with Health-HavenRx ™, an online pharmacy platform. This partnership enables a new, convenient channel for patients to access POGO Automatic by using their health insurance on Intuity Medical’s e-commerce website at www.GoodtoPogo.com.

By using this website you agree to accept Medical Device News Magazine Privacy Policy